Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin Nutr. 2023 Jan 11;42(2):235–243. doi: 10.1016/j.clnu.2023.01.009

Table 5.

Observed and Bayesian posterior means, 95% credible intervals and posterior probabilities of a dose effect for early preterm birth rate by quartile baseline DHA status and adherence (postpartum RBC-PL-DHA ≥8%) with the high dose.

Observed early preterm births <34 weeks, n/N (%) Posterior mean % of EPTB (95% Bayesian credible interval)a Bayesian posterior probabilities
200 mg 1000- mg 1000+ mg 200mg 1000- mg 1000+ mg 1000+ mg better than 200mg 1000+ mg better 1000- mg 1000- mg better than 200mg
DHA Enrollment (%)
 Quartile 1 (<5.1%] 5/112 (4.5) 4/96 (4.2) 1/46 (2.2) 3.4 (1.2,7.9) 2.5 (1.0,6.7) 1.3 (0.3,3.5) 0.92 0.82 0.67
 Quartile 2 (5.1–6.2%] 6/132 (4.6) 0/51 (0.0) 0/75 (0.0) 3.5 (1.5,7.7) 1.6 (0.0,4.4) 1.1 (0.3,2.6) 0.96 0.64 0.85
 Quartile 3 (6.2–7.4%] 1/110 (0.9) 1/52 (1.9) 2/86 (2.3) 1.3 (0.1,3.8) 1.9 (0.2,5.2) 1.3 (0.3,3.4) 0.48 0.66 0.32
 Quartile 4 (>7.4%)] 0/136 (0.0) 0/21 (0.0) 1/111 (0.9) 0.6 (0.0,3.3) 1.7 (0.0,5.0) 1.2 (0.2,2.8) 0.34 0.65 0.24
a

Bayesian hierarchical model was fitted using the approach in Berry and Berry,8 except mu~N(−3.1,10^2). This approach avoids false discoveries in subgroups (quartiles). We burned-in 10,000 draws. and used 40,000 draws for inference. High adherence, 1000+ mg, postpartum RBC-PL-DHA ≥ 8.0%; low adherence, 1000- mg, postpartum RBC-PL-DHA <8.0%.